Porvair PLC
LSE:PRV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Porvair PLC
LSE:PRV
|
UK |
|
M
|
Monnari Trade SA
WSE:MON
|
PL |
|
S
|
Savencia SA
F:BGJ
|
FR |
|
Invex Therapeutics Ltd
ASX:IXC
|
AU |
|
Henan Taloph Pharmaceutical Stock Co Ltd
SSE:600222
|
CN |
|
Silverline Endustri ve Ticaret AS
IST:SILVR.E
|
TR |
|
Patria Investments Ltd
NASDAQ:PAX
|
KY |
Wall Street
Price Targets
PRV Price Targets Summary
Porvair PLC
According to Wall Street analysts, the average 1-year price target for PRV is 1 016.6 GBX with a low forecast of 959.5 GBX and a high forecast of 1 102.5 GBX.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is PRV's stock price target?
Price Target
1 016.6
GBX
According to Wall Street analysts, the average 1-year price target for PRV is 1 016.6 GBX with a low forecast of 959.5 GBX and a high forecast of 1 102.5 GBX.
What is Porvair PLC's Revenue forecast?
Projected CAGR
7%
For the last 14 years the compound annual growth rate for Porvair PLC's revenue is 8%. The projected CAGR for the next 3 years is 7%.
What is Porvair PLC's Operating Income forecast?
Projected CAGR
7%
For the last 14 years the compound annual growth rate for Porvair PLC's operating income is 12%. The projected CAGR for the next 3 years is 7%.
What is Porvair PLC's Net Income forecast?
Projected CAGR
7%
For the last 14 years the compound annual growth rate for Porvair PLC's net income is 15%. The projected CAGR for the next 3 years is 7%.